2 lines
No EOL
1.3 KiB
Text
2 lines
No EOL
1.3 KiB
Text
"Project #","Project Title","Research Focus Area","Research Program","Administering IC(s)",Institution(s),Investigator(s),Location(s),"Year Awarded",Summary
|
|
1UG1DA059406-01,"Development and Validation of a Novel Point-of-Care Technology for Rapid Non-Targeted Identification of Emerging Opioid and Other Drug Threats","Novel Therapeutic Options for Opioid Use Disorder and Overdose","Rapidly Assessing the Public Health Impact of Emerging Opioid Threats",NIDA,"UNIVERSITY OF CALIFORNIA, SAN DIEGO","WERB, DANIEL M (contact); HALL, DREW ALEXANDER","La Jolla, CA",2023,"Drug checking services provide individuals who use drugs with information about the true contents of their purchases, and thus may help prevent overdoses. However, current technologies are either costly, technically complex, and non-portable or subject to false signals and restricted in their detection capabilities. This project will continue development of a new, simple-to-use, point-of-care analytical technology (DoseCheck) that can rapidly detect established drug threats in a sample and recognize newly emerging drugs. The project will also attempt to adapt DoseCheck to provide rapid results in emergency overdose situations and improve the analytical capabilities of medical examiners in under-resourced jurisdictions." |